Testing Tislelizumab Plus Capecitabine for Biliary Cancer
In the ever-evolving landscape of cancer therapy, biliary tract cancers (BTC) remain a formidable challenge due to their aggressive nature...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In the ever-evolving landscape of cancer therapy, biliary tract cancers (BTC) remain a formidable challenge due to their aggressive nature...
In a groundbreaking development that could reshape the therapeutic landscape for metastatic colorectal cancer (mCRC), researchers have unveiled compelling results...
In a groundbreaking study published in BMC Cancer, researchers have unveiled a promising new radiosensitizing agent, TOP-0618, a derivative of...
In the relentless fight against kidney cancer, clear cell renal cell carcinoma (ccRCC) stands as one of the most formidable...
Colorectal cancer (CRC) remains one of the deadliest malignancies worldwide, marked by uncontrolled growth of glandular epithelial cells within the...
In a groundbreaking study poised to redefine our understanding of ovarian cancer metabolism, researchers have unveiled a novel molecular mechanism...
In an era where precision medicine increasingly shapes cancer treatment, the ability to predict therapeutic outcomes with accuracy remains a...
In a breakthrough study that could reshape therapeutic approaches to one of the most lethal brain cancers, researchers have uncovered...
Venous thromboembolism (VTE) in pediatric populations represents a formidable clinical challenge, especially among children suffering from serious underlying medical conditions...
Philadelphia-based researchers from the Abramson Cancer Center at the University of Pennsylvania, alongside colleagues at Penn’s Perelman School of Medicine,...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine